Taken together, the results of this study provide new insights on HO-1 expression and distribution in the brain with aging and in AD-progression, that could pave the way to propose HO-1 as a potential biomarker or target for drug development for AD. This evidence concerns the gene HMOX1 and Alzheimer disease.